The purpose of the study is to compare the effects of glofitamab with combination of drugs. There will be two arms or groups. One group will receive glofitamab + Pola-R-CHP. The other group will receive only Pola-R-CHP. Pola-R-CHP includes: Polatuzumab vedotin, Rituximab, Cyclophosphamide, Doxorubicin, Prednisone
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Christopher Dittus
LCCC - Clinical Trials
Clinical or Medical
Interventional
Glands and Hormones
24-1335